ID
28042
Beschreibung
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Eligibility Question
Stichworte
Versionen (4)
- 27.08.17 27.08.17 -
- 13.10.17 13.10.17 -
- 23.10.17 23.10.17 -
- 12.12.17 12.12.17 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
12. Dezember 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Question GSK study Chronic Coronary Heart Disease NCT00799903
Eligibility Question GSK study Chronic Coronary Heart Disease NCT00799903
Beschreibung
Inclusion Criteria
Beschreibung
Subject must understand the aims, investigational procedures and possible consequences of the study).
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0021430
Beschreibung
Refer to Appendix 1: Highly Effective Methods For Avoidance Of Pregnancy In Women Of Childbearing Potential. The decision to include or exclude women of childbearing potential may be made at the discretion of the investigator in accordance with local practice in relation to adequate contraception.
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0150831
- UMLS CUI [1,2]
- C0001779
Beschreibung
statin therapy
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0360714
Beschreibung
Chronic CHD documented by at least one of the following: a. prior MI (>1 month prior to randomisation). b. prior coronary revascularization procedure [percutaneous coronary intervention (PCI) > 1 month prior to randomization or coronary artery bypass graft (CABG) >3 months prior to randomization]. c. multivessel CHD involving major epicardial coronary arteries confirmed by coronary angiography at any time (without revascularization).
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0010068
Beschreibung
At least one of the following additional predictors of CV risk [a through f]: a. age >60 years at randomization. b. diabetes mellitus requiring pharmacothearpy. c. HDL-C <40 mg/dL (1.03 mmol/L). d. smoker (defined as at least 5 cigarettes per day on average) or a previous smoker (defined as at least 5 cigarettes per day on average when smoking) who discontinued within the past 3 months. e. significant renal dysfunction (defined as estimated glomerular filtration rate [eGFR] >30 and <59 mL/min per 1.73 m2 OR urine ACR >30 mg albumin/g creatinine). f. polyvascular disease manifested as coexistent clinically diagnosed arterial disease in at least 2 arterial territories, defined as: > chronic CHD and cerebrovascular disease defined as carotid artery disease or prior ischemic stroke >3 months. OR > chronic CHD and peripheral arterial disease (PAD).
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0850624
Beschreibung
Exclusion Criteria
Beschreibung
Planned coronary revascularization
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0877341
Beschreibung
Current liver disease, known hepatic or biliary abnormalities (with the exception of Gilbert's syndrome or asymptomatic gallstones) or evidence of abnormal liver function test [total bilirubin or alkaline phosphatase >1.5 x upper limit of normal (ULN); or ALT or AST >2.5 x ULN] or other hepatic abnormalities that in the opinion of the Investigator would preclude the subject from participation in the study.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0023895
Beschreibung
renal impairment
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1565489
Beschreibung
heart failure
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0018801
Beschreibung
hypertension
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0020538
Beschreibung
(e.g., very severe chronic airways disease, known human immunodeficiency virus [HIV] positive, or cancer in the past five years other than non-melanoma skin cancer).
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C2826244
- UMLS CUI [1,2]
- C0012634
Beschreibung
asthma
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0004096
Beschreibung
All female subjects of childbearing potential must have a urine ß?-human chorionic gonadotropin [hCG] pregnancy test performed at Screening and/or within 7 days prior to randomization.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0032961
Beschreibung
Refer to Appendix 2: Clinical criteria for diagnosing anaphylaxis [Sampson, 2006]
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0002792
Beschreibung
Alcohol or drug abuse
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0038586
Beschreibung
intake CYP3A4 inhibitors
Datentyp
boolean
Alias
- UMLS CUI [1]
- C3830624
Beschreibung
Lp-PLA2 activity
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0031671
Beschreibung
exposure to darapladib
Datentyp
boolean
Alias
- UMLS CUI [1]
- C2348075
Beschreibung
Use of another investigational product
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0304229
Beschreibung
study of investigational device
Datentyp
boolean
Alias
- UMLS CUI [1]
- C2346570
Beschreibung
other reason for exclusion
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0680251
- UMLS CUI [1,2]
- C3840932
Ähnliche Modelle
Eligibility Question GSK study Chronic Coronary Heart Disease NCT00799903
C0001779 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,2])
C3840932 (UMLS CUI [1,2])